Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BYCureus

Comparative Evaluation of Two Commercially Available Topical Gels As Adjuncts to Scaling and Root Planing for Gingival Inflammation: A Randomized Controlled Trial.

  1. 1Periodontics, Himachal Pradesh Government Dental College and Hospital Shimla, Shimla, IND.

Abstract

Background

Gingivitis is a common plaque-induced inflammatory periodontal disease that may progress to periodontitis if left untreated. Adjunctive topical antimicrobial agents may improve the effectiveness of conventional periodontal therapy.Methods

This randomized controlled clinical trial included 120 participants with gingivitis or Stage I, Grade A periodontitis. Participants were randomly allocated to three groups: Group A received scaling and root planing (SRP) with placebo gel; Group B received SRP with 1% chlorhexidine gluconate (CHX) gel (CHX group); and Group C received SRP with a combination gel containing 0.5% CHX and 1.5% metronidazole (MTZ) (CHX+MTZ group). Plaque Index (PI), Gingival Index (GI), and probing pocket depth (PPD) were assessed at baseline and at 3, 6, and 12 weeks. Intergroup comparisons were performed using one-way analysis of variance and Tukey's post hoc test.Results

All 120 participants completed the study. Baseline intergroup differences were observed for PI (p = 0.010) and GI (p < 0.001), whereas PPD was comparable (p = 0.929). At 12 weeks, both test groups had lower PI and GI scores than the placebo group. Mean PI values were 1.273 ± 0.119 in Group A, 1.229 ± 0.051 in Group B, and 1.213 ± 0.048 in Group C (p = 0.013). Mean GI values were 1.256 ± 0.097, 1.209 ± 0.053, and 1.193 ± 0.053, respectively (p = 0.003). PI and GI did not differ significantly between Groups B and C at 12 weeks. PPD also remained comparable among groups (p = 0.241).Conclusions

Both CHX gel and the CHX-MTZ combination gel were associated with improvements in plaque control and gingival inflammation when used as adjuncts to SRP. No statistically significant difference was detected between the CHX and CHX+MTZ groups at 12 weeks. Therefore, the present findings do not establish an additional clinical advantage of adding MTZ to CHX under the conditions evaluated.

Related

  1. Comparative evaluation of the antipyretic and analgesic efficacy and safety of a fast-release paracetamol 650 mg formulation vs. conventional paracetamol formulations in adults with acute febrile or febrile-pain conditions: a multicenter randomized controlled trial
    Susobhan Mondal, S. K. Ashik Ikbal, Sumit Agrawal +11
    Frontiers in pain research (Lausanne, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Comparative evaluation of a novel dual sensory stimulation technique for reducing dental anxiety and improving behavior in pediatric patients: A randomized controlled trial
    Namrata Puri, Gauri Kalra, Madhulika Srivastava +3
    Journal of Indian Society of Pedodontics and Preventive DentistryPeer-reviewedCC BY-NC-SAFull textGeneral medicineDOAJ
  3. Comparative evaluation of mineral trioxide aggregate, diode and erbium, chromium-doped yttrium, scandium, gallium, and garnet laser-assisted mineral trioxide aggregate pulpotomy in primary molars – A randomized controlled trial
    Vishal Vishal, Gyanendra Kumar, Mridula Goswami +2
    Journal of Indian Society of Pedodontics and Preventive DentistryPeer-reviewedCC BY-NC-SAFull textGeneral medicineDOAJ
  4. Comparative effectiveness of novel laser-assisted technologies for treating peri-implantitis : A network meta-analysis of randomized controlled trials
    Zhe Wang, Jing Wen, Haoyang Li +2
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Comparative effects of supervised aerobic and combined training with dietary counseling on metabolic biomarkers in sedentary adult male bank employees: a randomized controlled trial
    Abrham Abebe, Alemmebrat Kiflu, Zeru Bekele
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0PhysiologyCrossref
BibTeX
@article{sharma2026comparative,
  title = {{Comparative Evaluation of Two Commercially Available Topical Gels As Adjuncts to Scaling and Root Planing for Gingival Inflammation: A Randomized Controlled Trial.}},
  author = {Abhishek Sharma and Ajay Mahajan and Kanwarjit Singh Asi},
  journal = {Cureus},
  year = {2026},
  month = sep,
  doi = {10.7759/cureus.116586},
  url = {https://europepmc.org/article/MED/42903836},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Comparative Evaluation of Two Commercially Available Topical Gels As Adjuncts to Scaling and Root Planing for Gingival Inflammation: A Randomized Controlled Trial.
AU  - Abhishek Sharma
AU  - Ajay Mahajan
AU  - Kanwarjit Singh Asi
PY  - 2026
DA  - 2026/09/20
JO  - Cureus
DO  - 10.7759/cureus.116586
UR  - https://europepmc.org/article/MED/42903836
AB  - Background  Gingivitis is a common plaque-induced inflammatory periodontal disease that may progress to periodontitis if left untreated. Adjunctive topical antimicrobial agents may improve the effectiveness of conventional periodontal therapy.Methods  This randomized controlled clinical trial included 120 participants with gingivitis or Stage I, Grade A periodontitis. Participants were randomly allocated to three groups: Group A received scaling and root planing (SRP) with placebo gel; Group B received SRP with 1% chlorhexidine gluconate (CHX) gel (CHX group); and Group C received SRP with a combination gel containing 0.5% CHX and 1.5% metronidazole (MTZ) (CHX+MTZ group). Plaque Index (PI), Gingival Index (GI), and probing pocket depth (PPD) were assessed at baseline and at 3, 6, and 12 weeks. Intergroup comparisons were performed using one-way analysis of variance and Tukey's post hoc test.Results  All 120 participants completed the study. Baseline intergroup differences were observed for PI (p = 0.010) and GI (p < 0.001), whereas PPD was comparable (p = 0.929). At 12 weeks, both test groups had lower PI and GI scores than the placebo group. Mean PI values were 1.273 ± 0.119 in Group A, 1.229 ± 0.051 in Group B, and 1.213 ± 0.048 in Group C (p = 0.013). Mean GI values were 1.256 ± 0.097, 1.209 ± 0.053, and 1.193 ± 0.053, respectively (p = 0.003). PI and GI did not differ significantly between Groups B and C at 12 weeks. PPD also remained comparable among groups (p = 0.241).Conclusions  Both CHX gel and the CHX-MTZ combination gel were associated with improvements in plaque control and gingival inflammation when used as adjuncts to SRP. No statistically significant difference was detected between the CHX and CHX+MTZ groups at 12 weeks. Therefore, the present findings do not establish an additional clinical advantage of adding MTZ to CHX under the conditions evaluated.
SN  - 2168-8184
ER  -